Reproductive Medicine and Infertility Associates

Augusta, Georgia 30904

Medical Director: Larisa Gavrilova-Jordan, MD

Reproductive Medicine and Infertility Associates in Augusta, Georgia, understands that your fertility journey can feel overwhelming, and they're here to provide both expert care and compassionate support. Under the leadership of Medical Director Dr. Larisa Gavrilova-Jordan, this clinic offers comprehensive fertility services including IVF, egg freezing, and surrogacy options to help you build the family you've been dreaming of.

What sets this practice apart is their impressive success rates and commitment to quality care. For patients under 35, they achieve a 63% live birth rate, while patients ages 35-37 see an even higher success rate of 80%. Their laboratory maintains verified accreditation, ensuring you receive care that meets the highest standards. With 218 treatment cycles completed in 2022, the team brings substantial experience to your unique situation. Rather than feeling like just another case number, you can trust that you're working with professionals who combine proven expertise with genuine understanding of what this journey means to you and your family.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3563.00%+14.651.80%48.4%
35–3780.00%+44.075.00%36%
38–4019.00%-4.6Not reported23.6%
Over 400.00%-9.50.00%9.5%

Based on 218 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.